Alloy Therapeutics
alloytx.comDeveloper of drug discovery platform designed to promote and facilitate antibody discovery projects.
LBX PPS
1Y return
$19.48
↓ 7.9% 1Y
Implied Valuation
$729.2M
-27.1% premium
Last Round
Apr 2026
Later Stage VC
Later Stage VC · $1.0B
Price per share
12M · USD
Loading chart...
Funding history
$M raised · $B post-money
Loading chart...
Explore related companies
More company profiles from the LBX Pro directory.